Loading stock data…
Loading stock data…
US$24.82
Get one email when PFE crosses your level. Checked every 15 minutes during market hours.
▲ +0.57 (2.35%)up today
Could not load chart data. Please try again shortly.
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
50.8
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.32
Bullish momentumMACD above its signal line (-0.42).
50-day average
25.32
Price belowShort-term trend reference.
200-day average
25.87
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Drug Manufacturers - General
Pfizer Inc. is a leading biopharmaceutical company that discovers, develops, manufactures, markets, distributes, and sells prescription drugs and vaccines worldwide. Operating in segments including Biopharma, PC1, and Pfizer Ignite, it focuses on key therapeutic areas such as oncology, cardiology, immunology, and infectious diseases. Notable products in its portfolio include the pneumococcal vaccine Prevnar 13, cardiovascular treatments like Vyndaqel and Eliquis, and oncology drug Padcev. Pfizer…
www.pfizer.com6 strong buy · 9 buy · 19 hold · 1 sell · 1 strong sell (36 analysts, 2026-07-01)
6 strong buy · 9 buy · 18 hold · 2 sell · 1 strong sell (36 analysts, 2026-06-01)
5 strong buy · 11 buy · 17 hold · 2 sell · 1 strong sell (36 analysts, 2026-05-01)
6 strong buy · 9 buy · 17 hold · 2 sell · 1 strong sell (35 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-05 | 0.72 | 0.75 | ✓ Beat |
| 2026-02-03 | 0.57 | 0.66 | ✓ Beat |
| 2025-11-04 | 0.63 | 0.87 | ✓ Beat |
| 2025-08-05 | 0.57 | 0.78 | ✓ Beat |
| 2025-04-29 | 0.67 | 0.92 | ✓ Beat |
| 2025-02-04 | 0.46 | 0.63 | ✓ Beat |
| 2024-10-29 | 0.61 | 1.06 | ✓ Beat |
| 2024-07-30 | 0.46 | 0.6 | ✓ Beat |
Companies in the same industry, via Finnhub